Hemogenyx Pharmaceuticals PLC Announces
Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company") U.S. Approval and Issuance of CDX Antibody Patent LONDON, UK / ACCESSWIRE / June 2, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing …
Weiterlesen »